Circulating cytokines and chemokines associated with plasma leakage and hepatic dysfunction in Brazilian children with dengue fever.
暂无分享,去创建一个
S. A. de Oliveira | O. Cruz | Ralph Antonio Xavier Ferreira | Solange Artimos de Oliveira | Mariana Gandini | Laura da Cunha Ferreira | Gladys Correa | Fernanda Mattos Abiraude | Mariana Mancebo Reid | Oswaldo Gonçalves Cruz | Claire Fernandes Kubelka | M. Gandini | C. Kubelka | Gladys Corrêa | R. X. Ferreira | M. M. Reid | L. C. Ferreira
[1] R. Rico-Hesse,et al. Dengue Virus Structural Differences That Correlate with Pathogenesis , 1999, Journal of Virology.
[2] R. Strong,et al. Structural insights into activation of antiviral NK cell responses , 2012, Immunological reviews.
[3] M. Teixeira,et al. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] A. Luster,et al. Dengue Virus Induces Expression of CXC Chemokine Ligand 10/IFN-γ-Inducible Protein 10, Which Competitively Inhibits Viral Binding to Cell Surface Heparan Sulfate1 , 2006, The Journal of Immunology.
[5] S. Sekaran,et al. Lack of Clinical Manifestations in Asymptomatic Dengue Infection Is Attributed to Broad Down-Regulation and Selective Up-Regulation of Host Defence Response Genes , 2014, PloS one.
[6] Sophie Yacoub,et al. The pathogenesis of dengue , 2013, Current opinion in infectious diseases.
[7] M. Haine,et al. Van Damme A. , 1986 .
[8] Y. Liaw,et al. Liver biochemical tests and dengue fever. , 1992, The American journal of tropical medicine and hygiene.
[9] M. Sinniah,et al. Augmented inflammatory cytokines in primary dengue infection progressing to shock. , 1995, Singapore medical journal.
[10] Trai-Ming Yeh,et al. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. , 2006, The Journal of general virology.
[11] Y. Teo,et al. Genome-wide association study identifies susceptibility loci for Dengue shock syndrome at MICB and PLCE1 , 2011, Nature Genetics.
[12] E. Azeredo,et al. Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection , 2005, BMC infectious diseases.
[13] S. Yoksan,et al. Alteration of Cytokines and Chemokines During Febrile Episodes Associated With Endothelial Cell Damage and Plasma Leakage in Dengue Hemorrhagic Fever , 2012, The Pediatric infectious disease journal.
[14] Kuender D Yang,et al. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. , 2005, FEMS immunology and medical microbiology.
[15] A. M. Alves,et al. Regulation of Inflammatory Chemokine Receptors on Blood T Cells Associated to the Circulating Versus Liver Chemokines in Dengue Fever , 2012, PloS one.
[16] X. Fang,et al. Genetic polymorphisms of molecules involved in host immune response to dengue virus infection. , 2012, FEMS immunology and medical microbiology.
[17] K. Asadullah,et al. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment , 1997, Nature Medicine.
[18] Joshy George,et al. Host Gene Expression Profiling of Dengue Virus Infection in Cell Lines and Patients , 2007, PLoS neglected tropical diseases.
[19] A. Nisalak,et al. Early clinical and laboratory indicators of acute dengue illness. , 1997, The Journal of infectious diseases.
[20] Mark J. Schreiber,et al. Characterization of early host responses in adults with dengue disease , 2011, BMC infectious diseases.
[21] Susana Vázquez,et al. IL‐10 levels in Dengue patients: Some findings from the exceptional epidemiological conditions in Cuba , 2004, Journal of medical virology.
[22] E L Braga,et al. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. , 2001, Memorias do Instituto Oswaldo Cruz.
[23] Fernando A Bozza,et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity , 2008, BMC infectious diseases.
[24] S. Wahid,et al. A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. , 2000, The Southeast Asian journal of tropical medicine and public health.
[25] A. Nisalak,et al. Elevated plasma interleukin‐10 levels in acute dengue correlate with disease severity , 1999, Journal of medical virology.
[26] B. Wu-Hsieh,et al. Intrahepatic Infiltrating NK and CD8 T Cells Cause Liver Cell Death in Different Phases of Dengue Virus Infection , 2012, PloS one.
[27] P. Marianneau,et al. Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. , 1999, Human pathology.
[28] Ulisses Braga-Neto,et al. Reliable Classifier to Differentiate Primary and Secondary Acute Dengue Infection Based on IgG ELISA , 2009, PloS one.
[29] D. Hober,et al. Serum Levels of Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1β (IL-1β) in Dengue-Infected Patients , 1993 .
[30] A. McMichael,et al. T Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal?1 , 2006, The Journal of Immunology.
[31] S. Sekaran,et al. Cytokine Expression Profile of Dengue Patients at Different Phases of Illness , 2012, PloS one.
[32] A. Srikiatkhachorn. Plasma leakage in dengue haemorrhagic fever , 2009, Thrombosis and Haemostasis.
[33] S. Kalayanarooj,et al. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. , 2007, The Journal of general virology.
[34] M. Guzmán,et al. Apoptosis in tissues from fatal dengue shock syndrome. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[35] R. Nogueira,et al. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. , 2004, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[36] F. Bozza,et al. MACROPHAGE MIGRATION INHIBITORY FACTOR LEVELS CORRELATE WITH FATAL OUTCOME IN SEPSIS , 2004, Shock.
[37] R. Souza-Santos,et al. Change in Age Pattern of Persons with Dengue, Northeastern Brazil , 2011, Emerging infectious diseases.
[38] M. Siqueira,et al. Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP-1β and CCL2/MCP-1 in dengue fever and parvovirosis. , 2012, Memorias do Instituto Oswaldo Cruz.
[39] C. Sant’Anna,et al. Characteristics of children hospitalized with dengue fever in an outbreak in Rio de Janeiro, Brazil. , 2011, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[40] Graham S. Ogg,et al. Cellular and Cytokine Correlates of Severe Dengue Infection , 2012, PloS one.
[41] Roberto da Justa Pires Neto,et al. Dengue infection in children and adolescents: clinical profile in a reference hospital in northeast Brazil. , 2013, Revista da Sociedade Brasileira de Medicina Tropical.
[42] J. Bernhagen,et al. The vascular biology of macrophage migration inhibitory factor (MIF) , 2013, Thrombosis and Haemostasis.
[43] A. Luster. The role of chemokines in linking innate and adaptive immunity. , 2002, Current opinion in immunology.
[44] T. Calandra,et al. Macrophage migration inhibitory factor: a regulator of innate immunity , 2003, Nature Reviews Immunology.
[45] C. Biron,et al. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. , 2000, The Journal of clinical investigation.
[46] Trai-Ming Yeh,et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. , 2006, The American journal of tropical medicine and hygiene.
[47] A. Tanuri,et al. Two Lineages of Dengue Virus Type 2, Brazil , 2010, Emerging infectious diseases.
[48] N. Wauquier,et al. Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production , 2010, BMC infectious diseases.
[49] H. F. de Andrade,et al. Immunopathogenesis of dengue hemorrhagic fever: Contribution to the study of human liver lesions , 2014, Journal of medical virology.
[50] S. Halstead,et al. Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.
[51] G. Ogg,et al. Suppression of Virus Specific Immune Responses by IL-10 in Acute Dengue Infection , 2013, PLoS neglected tropical diseases.
[52] A. Pacheco,et al. Single nucleotide polymorphisms in candidate genes and dengue severity in children: a case-control, functional and meta-analysis study. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[53] R. Cunha,et al. Clinical and laboratory findings in patients with dengue associated with hepatopathy. , 2011, Revista da Sociedade Brasileira de Medicina Tropical.
[54] P. Proost,et al. Overview of the mechanisms regulating chemokine activity and availability. , 2012, Immunology letters.
[55] E. Azeredo,et al. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. , 2001, Immunobiology.
[56] S. López-Vergès,et al. NK Cells during Dengue Disease and Their Recognition of Dengue Virus-Infected cells , 2014, Front. Immunol..
[57] T. Hien,et al. Liver Involvement Associated with Dengue Infection in Adults in Vietnam , 2010, The American journal of tropical medicine and hygiene.
[58] R. Nogueira,et al. Dengue haemorrhagic fever in the state of Rio de Janeiro, Brazil: a study of 56 confirmed cases. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[59] S. Halstead,et al. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. , 2004, The Journal of infectious diseases.
[60] T. Vitarana,et al. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. , 1991, The Ceylon medical journal.
[61] A. Waage,et al. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease , 1995, Infection and immunity.
[62] O. Bagasra,et al. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. , 1997, Cytokine & growth factor reviews.